Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

• Nesyrgy combines a calcium channel blocker and a beta‑blocker to manage elevated blood pressure.
• Hypertension: reduces systolic and diastolic blood pressure in adult patients with primary hypertension.

• Amlodipine Besilate blocks L‑type calcium channels in vascular smooth muscle, causing vasodilation and reduced peripheral resistance. Nebivolol Hydrochloride selectively antagonises β1‑adrenergic receptors, decreasing heart rate and contractility, while also stimulating endothelial nitric‑oxide release for additional vasodilation. The complementary actions lower systemic blood pressure.

Common Side Effects

• Peripheral edema: mild swelling of the ankles or feet.
• Headache: transient throbbing pain, often related to vasodilation.
• Flushing: warmth and redness of the skin, especially on the face.
• Dizziness: sensation of light‑headedness, particularly after standing.
• Fatigue: general tiredness without exertion.
• Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure that may cause fainting.
• Bradycardia: unusually slow heart rate that can lead to dizziness or syncope.
• Heart block: impaired electrical conduction requiring medical attention.
• Liver enzyme elevation: abnormal liver function tests indicating possible hepatic stress.
• Angio‑edema: rapid swelling of lips, tongue, or throat that can compromise breathing.
• Allergic reaction: rash, itching, or swelling indicating hypersensitivity.

Before initiating therapy, clinicians should consider individual patient factors and monitor for adverse reactions.

• Blood pressure monitoring: check regularly to ensure therapeutic targets are met.
• Cardiac assessment: evaluate heart rate and rhythm, especially in patients with pre‑existing conduction disorders.
• Gradual dose changes: avoid abrupt discontinuation to prevent rebound hypertension.
• Hepatic function: adjust use in patients with moderate to severe liver impairment.
• Drug‑specific counseling: advise patients to rise slowly to reduce orthostatic symptoms.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nesyrgy may interact with other medicines that affect blood pressure or drug metabolism.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase amlodipine exposure.
• Non‑selective beta‑blockers (e.g., propranolol): additive bradycardia and hypotension.
• Other antihypertensives (e.g., ACE inhibitors, ARBs): risk of excessive blood pressure lowering.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance hypotensive effect, requiring dose adjustment.
• Digoxin: nebivolol can increase serum digoxin levels.
• Moderate CYP3A4 inhibitors (e.g., clarithromycin, erythromycin): may modestly raise amlodipine concentrations.
• Antidiabetic agents: blood glucose may fall, necessitating closer monitoring.
• NSAIDs: can blunt antihypertensive response, especially in sodium‑retaining individuals.